The most commonly reported adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, rather than neurological pain syndromes
If this side effect becomes too much to handle, your healthcare provider might consider switching you to a different medication in the same class, such as tirzepatide (Mounjaro or Zepbound), to see if your symptoms improve
Up to Date
Practical, clinician-conversation-ready guidance on switching glp-1 medications with a structured GLP-1 tracking framework
Atoms are shown as color-coded: hydrogen (white), carbon (grey), nitrogen (blue), oxygen (red)
Safety The safety and tolerability of semaglutide and metformin were also evaluated in this population